MedCap Corp. (MPCPF.PK) Urges Vote Against Proposed VaxGen, Inc. (VXGN) Merger With Raven Biotechnologies, Inc.
3/20/2008 9:10:06 AM
SAN FRANCISCO--(BUSINESS WIRE)--MedCap Management & Research LLC and its affiliates (“MedCap”), a substantial VaxGen Inc. (VXGN) shareholder, urge all VaxGen shareholders to vote AGAINST the proposed merger with Raven biotechnologies, inc. (“Raven”), on or before the upcoming scheduled shareholder meeting on March 28, 2008, and to vote AGAINST the Adoption of VaxGen’s 2008 Equity Incentive Plan. MedCap intends to vote all of its VaxGen shares against the proposed transaction and against the proposed equity incentive plan. MedCap continues to hold approximately 4.8% of the company’s stock.